DE68919282T2 - Verfahren zur Herstellung von Cephalosporin und Zwischenverbindungen. - Google Patents

Verfahren zur Herstellung von Cephalosporin und Zwischenverbindungen.

Info

Publication number
DE68919282T2
DE68919282T2 DE68919282T DE68919282T DE68919282T2 DE 68919282 T2 DE68919282 T2 DE 68919282T2 DE 68919282 T DE68919282 T DE 68919282T DE 68919282 T DE68919282 T DE 68919282T DE 68919282 T2 DE68919282 T2 DE 68919282T2
Authority
DE
Germany
Prior art keywords
cephalosporin
intermediates
preparation
production
antiobiotics
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE68919282T
Other languages
English (en)
Other versions
DE68919282D1 (de
Inventor
Meseguer Jose Diago
Bianchini Asuncion Esteve
Padro Carlos E Lenhardt
Pitarch Esteve Sans
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz Industrial Products SA
Original Assignee
Biochemie SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biochemie SA filed Critical Biochemie SA
Publication of DE68919282D1 publication Critical patent/DE68919282D1/de
Application granted granted Critical
Publication of DE68919282T2 publication Critical patent/DE68919282T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/587—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with aliphatic hydrocarbon radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms, said aliphatic radicals being substituted in the alpha-position to the ring by a hetero atom, e.g. with m >= 0, Z being a singly or a doubly bound hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE68919282T 1988-06-20 1989-06-16 Verfahren zur Herstellung von Cephalosporin und Zwischenverbindungen. Expired - Fee Related DE68919282T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES8801910A ES2006988A6 (es) 1988-06-20 1988-06-20 Procedimiento de preparar hidrocloruro cloruro-2-(2-aminotiazol-4-il)-2-metoxiiminoacetil-sulfito-dimetilformiminio y procedimiento de utilizacion del mismo para obtencion de amidas.

Publications (2)

Publication Number Publication Date
DE68919282D1 DE68919282D1 (de) 1994-12-15
DE68919282T2 true DE68919282T2 (de) 1995-05-24

Family

ID=8256891

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68919282T Expired - Fee Related DE68919282T2 (de) 1988-06-20 1989-06-16 Verfahren zur Herstellung von Cephalosporin und Zwischenverbindungen.

Country Status (6)

Country Link
US (1) US5037988A (de)
EP (1) EP0347777B1 (de)
JP (1) JPH0245478A (de)
AT (1) ATE113939T1 (de)
DE (1) DE68919282T2 (de)
ES (2) ES2006988A6 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9423459D0 (en) * 1994-11-21 1995-01-11 Biochemie Gmbh Silylation process
AT402928B (de) * 1994-12-23 1997-09-25 Biochemie Gmbh Neues verfahren zur herstellung von cefotaxim
IN181459B (de) * 1995-12-26 1998-06-20 Lupin Lab Ltd
EP0791597B1 (de) * 1996-02-21 2000-07-12 Lupin Laboratories Limited Verfahren zur Herstellung von Cephalosporinderivaten und Zwischenverbindungen
EP0791596A1 (de) * 1996-02-21 1997-08-27 Lupin Laboratories Limited Verfahren zur Herstellung von Cephalosporinen und seine Zwischenverbindungen
US6610845B1 (en) 2002-01-04 2003-08-26 Orchid Chemicals & Pharmaceuticals Limited, India Thioester derivatives of thiazolyl acetic acid and their use in the preparation of cephalosporin compounds
AU2002368505A1 (en) * 2002-12-26 2004-07-22 Lupin Limited Novel intermediates for synthesis of cephalosporins and process for preparation of such intermediates
WO2005076694A2 (en) * 2004-01-16 2005-08-25 Wockhardt Limited Improved process for the production of cefotaxime sodium
CN102702233A (zh) * 2012-05-18 2012-10-03 苏州中联化学制药有限公司 头孢曲松钠的制备方法
CN109503630A (zh) * 2018-12-14 2019-03-22 河北合佳医药科技集团股份有限公司 一种去乙酰头孢噻肟的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2060460A5 (de) * 1968-12-21 1971-06-18 Coll Antonio
US4871860A (en) * 1976-04-12 1989-10-03 Fujisawa Pharmaceutical Co., Ltd. Syn-isomer of 3,7-disubstituted-3-cephem-4-caroxylic acid compounds and processes for the preparation thereof
FR2462439A1 (fr) * 1979-07-26 1981-02-13 Roussel Uclaf Nouveau procede de preparation de produits derives de l'acide 7-/(2-aryl) 2-hydroxyimino acetamido/cephalosporanique
DE3419015A1 (de) * 1984-05-22 1985-11-28 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von cephalosporinen
DE3542644A1 (de) * 1985-12-03 1987-06-04 Hoechst Ag Verfahren zur herstellung von cefodizim

Also Published As

Publication number Publication date
EP0347777B1 (de) 1994-11-09
ES2006988A6 (es) 1989-05-16
DE68919282D1 (de) 1994-12-15
ES2065944T3 (es) 1995-03-01
EP0347777A3 (de) 1991-08-28
EP0347777A2 (de) 1989-12-27
JPH0245478A (ja) 1990-02-15
ATE113939T1 (de) 1994-11-15
US5037988A (en) 1991-08-06

Similar Documents

Publication Publication Date Title
DE69126762D1 (de) Biologisches Verfahren zur Herstellung von Alpha-Hydroxyamid und Alpha-Hydroxysäure
DE3880438T2 (de) Verfahren zur Herstellung von Aktivkohle.
FI103506B1 (fi) Menetelmä syklisten aminohappojohdannaisten valmistamiseksi ja menetelmässä käytettävä välituote
DE69132176T2 (de) Verfahren zur Herstellung von Elektroden
DE3884973T2 (de) Verfahren zur Herstellung von Avermectine-B und die verwendeten Kulturen.
DE3863170D1 (de) Mesophasenpech zur herstellung von kohlenstoffkoerpern und verfahren zur herstellung derselben.
DE69131217T2 (de) Verfahren zur Herstellung von R(-)Mandelsäure und deren Derivaten
DE68919246T2 (de) Verfahren zur Herstellung von Aminosäuren.
DE69024909T2 (de) Verfahren zur Herstellung von Polyimid-Verbundstoffen
DE68916086D1 (de) Verfahren zur Herstellung von Kohlenstoff/Kohlenstoff-Verbundstoffen.
DE69026476T2 (de) Verfahren zur Herstellung von 5-Fluorbenzoesäuren und deren Zwischenprodukten
DE69004648T2 (de) Verfahren zur Herstellung von Alpha-Hydroxycarbonsäure-Amiden.
DE68919282T2 (de) Verfahren zur Herstellung von Cephalosporin und Zwischenverbindungen.
DE69020172D1 (de) Verfahren zur Herstellung von epsilon-Caprolactam.
DE3854799D1 (de) Verfahren zur Herstellung von veränderten Zeolithen
DE3650008T2 (de) Katalytische Zusammensetzung und Verfahren zur Herstellung von Silanen.
DE68928398D1 (de) Verfahren zur Herstellung von Polybuten
DE3851588D1 (de) Verfahren zur Herstellung von Chinoloncarbonsäuren.
DE68916760D1 (de) Verfahren zur Herstellung von Gamma-Lactonen.
DE68926922D1 (de) Verfahren zur Herstellung von L-alpha-Aminosäuren
DE3688302T2 (de) Verfahren zur Herstellung von 7-ACA-Derivaten.
DE69225560D1 (de) Verfahren zur Herstellung von Lactonen
DE3888317D1 (de) Verfahren zur Herstellung von Phosphorsäurederivaten und Zwischenprodukten.
ATE94538T1 (de) Verfahren zur herstellung von harnstoffen.
DE3884324D1 (de) Verfahren zur Herstellung von menschlichen pro-apolipoprotein-A-I-ähnlichen Proteinen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee